Research Archive — Page 110 of 135
-
November 29, 2018
Green tea and diabetes
In a large population study of Chinese adults, Vanderbilt researchers found that green tea drinking increased risk of type 2 diabetes. -
November 29, 2018
Lung cancer survival signal
A receptor thought to be a cell growth inhibitor actually sends pro-survival signals in small cell lung cancer and is a candidate biomarker for poor prognosis. -
November 29, 2018
Parsing diabetic skin infections
Vanderbilt researchers have discovered a role for an inflammatory mediator in diabetic skin infections, suggesting new therapeutic targets for this common complication of diabetes. -
November 15, 2018
Lynn Maquat, PhD, to give Vanderbilt Prize lecture Nov. 29
Lynne Maquat, PhD, recipient of the 2017 Vanderbilt Prize in Biomedical Science whose work has advanced our understanding of human gene expression, will deliver her Vanderbilt Prize lecture as part of the Flexner Discovery Lecture series on Nov. 29. -
November 15, 2018
Immunotherapies linked to specific heart complications
In the first large-scale analysis of cardiovascular complications linked to immune checkpoint inhibitors, Vanderbilt researchers have shown that heart and vessel complications include myocarditis, pericarditis, vasculitis and arrhythmias, and that they occur early in the course of treatment. -
November 8, 2018
Evading cell death
Stress granules that form in response to cellular stress help cancer cells survive and develop resistance to treatment. -
November 8, 2018
Vitamin C protects brain from seizures
Brain ascorbate — vitamin C — is important for protecting the brain against seizures and cognitive decline in Alzheimer’s disease.